• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Critical Care - Gattinoni c.s. - COVID-19 pneumonia: ARDS or not? - Clinical implications

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
Critical Care volume 24, Article number: 154 (2020) Cite this article
  • 3086 Accesses
  • 124 Altmetric
  • Metrics

Even though it can meet the ARDS Berlin definition [1, 2], the COVID-19 pneumonia is a specific disease with peculiar phenotypes. Its main characteristic is the dissociation between the severity of the hypoxemia and the maintenance of relatively good respiratory mechanics. Indeed, the median respiratory system compliance is usually around 50 ml/cmH[SUB]2[/SUB]O. Of note, the patients with respiratory compliance lower or higher than the median value experience hypoxemia of similar severity.

We propose the presence of two types of patients (“non-ARDS,” type 1, and ARDS, type 2) with different pathophysiology.

When presenting at the hospital, type 1 and type 2 patients are clearly distinguishable by CT scan (Fig. 1). If the CT scan is not available, the respiratory system compliance and possibly the response to PEEP are the only imperfect surrogates we may suggest.


.............................

Type 1 patients:

  • PEEP levels should be kept lower in patients with high pulmonary compliance
  • Tidal volume thresholds should not be limited at 6 ml/kg
  • Respiratory rate should not exceed 20 breaths/min
  • Patients should be left “quiet”; avoiding doing too much is of higher benefit than intervening at any cost.
Type 2 patients:
  • Standard treatment for severe ARDS should be applied (lower tidal volume, prone positioning, and relatively high PEEP).
 
Back
Top